Reata Pharmaceuticals Inc RETA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 06/22/21 EDT
140.33quote price arrow up+140.33 (UNCH)
Volume
1,633
Close
140.33quote price arrow up+2.89 (+2.10%)
Volume
321,861
52 week range
76.34 - 186.82

...

Loading . . .
  • Open137.14
  • Day High140.90
  • Day Low135.58
  • Prev Close140.33
  • 52 Week High186.82
  • 52 Week High Date11/10/20
  • 52 Week Low76.34
  • 52 Week Low Date05/14/21

Key Stats

  • Market Cap5.091B
  • Shares Out36.28M
  • 10 Day Average Volume0.30M
  • Dividend-
  • Dividend Yield-
  • Beta1.52
  • YTD % Change13.52

KEY STATS

  • Open137.14
  • Day High140.90
  • Day Low135.58
  • Prev Close140.33
  • 52 Week High186.82
  • 52 Week High Date11/10/20
  • 52 Week Low76.34
  • 52 Week Low Date05/14/21
  • Market Cap5.091B
  • Shares Out36.28M
  • 10 Day Average Volume0.30M
  • Dividend-
  • Dividend Yield-
  • Beta1.52
  • YTD % Change13.52

RATIOS/PROFITABILITY

  • EPS (TTM)-7.74
  • P/E (TTM)-18.14
  • Fwd P/E (NTM)-15.20
  • EBITDA (MRQ)-212.741M
  • ROE (MRQ)-89.09%
  • Revenue (MRQ)8.61M
  • Gross Margin (MRQ)-1,432.42%
  • Net Margin (MRQ)-3,093.70%
  • Debt To Equity (MRQ)20.35%

EVENTS

  • Earnings Date08/09/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Reata Pharmaceuticals Inc

There is no recent news for this security.

Latest From Our Partners

Profile

MORE
Reata Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on identifying, developing and commercializing product candidates that modulate the activity of regulatory proteins involved in the biology of mitochondrial function, oxidative stress, and inflammation to address the unmet medical needs of patients with a range of serious or life-threatening diseases. The Company's lead product candidates include bardoxolone methyl, which is...
J. Warren Huff
Chairman
Manmeet Soni CPA
Chief Financial Officer
Michael Wortley
Executive Vice President
Colin Meyer M.D.
Executive Vice President
Dawn Bir
Executive Vice President
Address
5320 Legacy Dr
Plano, TX
75024-3127
United States

Top Peers

SYMBOLLASTCHG%CHG
EIDX
ALLK
Allakos Inc
90.74-2.04-2.20%
IBRX
Immunitybio Inc
13.66-0.11-0.80%
BEAM
Beam Therapeutics Inc
85.99+0.07+0.08%
TGTX
TG Therapeutics Inc
37.54-0.17-0.45%